September Is Sickle Cell Awareness Month – Shivom

KEY TAKEAWAYS:

• Shivom forms partnership with eMQT and is participating in the September Sickle Cell awareness campaign
• They invite patients, physicians, and researchers to share their experiences with the disease on their social channels
• Plans progress with their India Diabetes campaign- at the end of September, CEO Henry Ines and CSO Axel Schumacher, will be starting work with a large diagnostics clinic to initiate patient sample collection in Andhra Pradesh

Following our announced partnership with eMQT, we are participating in the September Sickle Cell awareness campaign in order to show our support for the millions worldwide who suffer from this disease. We are are inviting patients, physicians, and researchers to share their experiences with the disease on our social channels. Sickle Cell Disease (“SCD”) is the most prevalent genetic blood disorder, in which the red blood cells are morphologically unable to deliver enough oxygen to the human body, and affects nearly 3% of infants every year.

Read more about our partnership with eMQT here: https://www.cryptoninjas.net/ 2018/08/07/dna-data- blockchain-shivom-omx- partners-with-emqt-to-improve- sickle-cell-disease-treatment/

How to share your experience? 
Follow us, Tweet at us @ProjectShivom, and use the hashtag #SickleCellAwareness
Don’t forget to join our Telegram chat https://t.me/projshivom, or send us your stories [email protected]

Moving Forward with Diabetes Pilot In India 

We are thrilled by the high-interest shown by our community to be the first to test our Alpha Release. Stay tuned for more information regarding the release date and details for logging into the platform.

Towards the end of September our CEO Henry Ines and CSO Axel Schumacher will be starting work with a large diagnostics clinic to initiate patient sample collection in Andhra Pradesh. The work will involve setting up processes and procedures for the sample collection pilot. The subsequent work will require collecting samples from 1500 type II diabetes and 1500 control patients with the goal of creating a type II diabetes diagnostic SNP panel for the Indian population with our partner Genetic Technologies in Australia. Our platform is being developed in parallel to handle this data collection and ensure secure storage of this data using blockchain.

About Shivom

Shivom combines blockchain, A.I., DNA sequencing & cryptography to enable secure and personalized medicine. The Shivom platform works on collaboration & integrity, allowing people to own, manage and monetize their data. By creating a web-marketplace, a network of genomic counsellors, and a not-for-profit drug research unit, Shivom will build a global healthcare ecosystem, reaching even low-income countries.

Register Interest